Patricia Andrews - Sumitomo Dainippon Executive Officer, CEO of Subsidiary

DNPUF Stock  USD 2.40  0.00  0.00%   

CEO

Patricia Andrews is Executive Officer, CEO of Subsidiary of Sumitomo Dainippon Pharma since 2017.
Age 60
Tenure 7 years
Phone81 6 6203 5321
Webhttps://www.sumitomo-pharma.com

Sumitomo Dainippon Management Efficiency

Sumitomo Dainippon's management efficiency ratios could be used to measure how well Sumitomo Dainippon manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 243.96 B in total debt with debt to equity ratio (D/E) of 0.36, which is about average as compared to similar companies. Sumitomo Dainippon Pharma has a current ratio of 1.71, which is within standard range for the sector. Debt can assist Sumitomo Dainippon until it has trouble settling it off, either with new capital or with free cash flow. So, Sumitomo Dainippon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sumitomo Dainippon Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sumitomo to invest in growth at high rates of return. When we think about Sumitomo Dainippon's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Anre WilliamsAmerican Express
58
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people. Sumitomo Dainippon Pharma [DNPUF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Sumitomo Dainippon Pharma Leadership Team

Elected by the shareholders, the Sumitomo Dainippon's board of directors comprises two types of representatives: Sumitomo Dainippon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo Dainippon's management team and ensure that shareholders' interests are well served. Sumitomo Dainippon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo Dainippon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nobuhiko Tamura, Managing Executive Officer
Kazuo Koshiya, Executive Officer, Manager of Oncology Business Promotion Office
Saeko Arai, Independent Director
Masayo Tada, CEO and President Representative Director and Chairman of Risk Management Committee
Takuya Taguchi, Sr Unit
Hideyuki Harada, Executive Officer, Chief Director of Research
Makoto Hara, Senior Managing Executive Officer, Director
Hitoshi Odagiri, Executive Officer and Director of Personnel and Career Devel. Support
Yutaka Atomi, Independent Director
Yoshinori Ohe, Executive Officer, Director of Business Development
Kazuhiro Takada, Executive Officer, Director of Corporate Governance
Yoshihiro Okada, Managing Executive Officer, Chief Director of Production, Director
Hajime Kinuta, Executive Officer, Director of Business Planning
Susumu Nakajima, Sr. Executive Officer and Executive Director of Sales and Marketing
Hiroyuki Baba, Executive Officer
Toru Kimura, Executive Officer, Manager of Regeneration & Cell Medicine Business Promotion Office
Patricia Andrews, Executive Officer, CEO of Subsidiary
Hiroshi Sato, Independent Director
Hidehiko Sato, Independent Director
Yoshiharu Ikeda, Executive Officer, Chief Director of Technology Research
Hiroshi Noguchi, Sr. Executive VP, Executive Director of Drug Research and Representative Director
Nobuyuki Hara, Executive Officer, Chief Director of Reliability Guarantee
Naoki Noguchi, Corp Governance
Hisayoshi Kashima, Director of Accounting
Masaru Ishidahara, Sr. Executive Officer and Director
Chiang Li, Executive Officer
Mitsuyuki Taniguchi, Executive Officer, Deputy Chief Director of Sales
Hiroshi Nomura, Director
Atsuko Higuchi, Executive Officer
Shigeyuki Nishinaka, Executive Officer, Director of Business Development
Antony Loebel, Executive Officer

Sumitomo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sumitomo Dainippon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sumitomo Dainippon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sumitomo Dainippon's short interest history, or implied volatility extrapolated from Sumitomo Dainippon options trading.

Pair Trading with Sumitomo Dainippon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sumitomo Dainippon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will appreciate offsetting losses from the drop in the long position's value.

Moving against Sumitomo Pink Sheet

  0.78TEVA Teva PharmaceuticalPairCorr
  0.76SCSC ScanSource Financial Report 14th of May 2024 PairCorr
  0.76LYFT LYFT Inc Financial Report 2nd of May 2024 PairCorr
  0.75MKKGY Merck KGaA ADRPairCorr
  0.74MKGAF MERCK KommanditgesellsPairCorr
The ability to find closely correlated positions to Sumitomo Dainippon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sumitomo Dainippon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sumitomo Dainippon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sumitomo Dainippon Pharma to buy it.
The correlation of Sumitomo Dainippon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sumitomo Dainippon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sumitomo Dainippon Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sumitomo Dainippon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Sumitomo Pink Sheet analysis

When running Sumitomo Dainippon's price analysis, check to measure Sumitomo Dainippon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Dainippon is operating at the current time. Most of Sumitomo Dainippon's value examination focuses on studying past and present price action to predict the probability of Sumitomo Dainippon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Dainippon's price. Additionally, you may evaluate how the addition of Sumitomo Dainippon to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Please note, there is a significant difference between Sumitomo Dainippon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sumitomo Dainippon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sumitomo Dainippon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.